Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins

Antiviral Research

Volumn 62, Issue 3, 2004, Pages 135-137

  Grancher, Nicolas ^a,b   Venard, Véronique ^a   Kedzierewicz, Francine ^a   Ammerlaan, Wim ^b   Finance, Chantal ^a   Muller, Claude P ^b   Le Faou, Alain ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Antiviral activity; Cyclodextrins; Measles virus; Ribavirin

Indexed keywords

ALPHA CYCLODEXTRIN; ANTIVIRUS AGENT; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SENSITIVITY; IN VITRO STUDY; MEASLES VIRUS; MINIMUM INHIBITORY CONCENTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS INHIBITION;

ANIMALS; CERCOPITHECUS AETHIOPS; CYCLODEXTRINS; DRUG COMPOUNDING; DRUG STABILITY; MEASLES VIRUS; MICROBIAL SENSITIVITY TESTS; RIBAVIRIN; VERO CELLS;

MEASLES VIRUS; MINK ENTERITIS VIRUS;

EID: 2342635857     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.01.003     Document Type: Article

References (20)

1. Abdou S., Collomb J., Sallas F., Marsura A., Finance C. Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence. Arch. Virol. 142:1997;1585-1602
2. Al-Omar A., Abdou S., De Robertis L., Marsura A., Finance C. Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line. Bioorg. Med. Chem. Lett. 9:1999;1115-1120
3. Barnard D.L., Xu Z.Q., Stowell V.D., Yuan H., Smee D.F., Samy R., Sidwell R.W., Nielsen M.K., Sun L., Cao H., Li A., Quint C., Deignan J., Crabb J., Flavin M.T. Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication. Antiviral Chem. Chemother. 13:2002;39-59
4. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942
5. Gangemi J.D., Nachtigal M., Barnhart D., Krech L., Jani P. Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus. J. Infect. Dis. 155:1987;510-517
6. Glue P. The clinical pharmacology of ribavirin. Semin. Liver. Dis. 19(Suppl. 1):1999;17-24
7. Grancher, N., Kedzierewicz, F., Venard, V., Finance, C., Marsura, M., Le Faou, A., 2004. Physicochemical study of ribavirin complexes with α-, β- and γ-cyclodextrins. J. Inclus. Phenomena Macrocycl. Chem., accepted for publication.
8. Gururangan S., Stevens R.F., Morris D.J. Ribavirin response in measles pneumonia. J. Infect. 20:1990;219-221
9. Higuchi, T., Connors, K.A., 1965. Phase solubility techniques. In: Reilley, C.N. (Ed.), Advances in Analytical Chemistry and Instrumentation, New York, vol. 4, pp. 117-212.
10. Isenberg, H.D., 1992. In: Isenberg, H.D. (Ed.), Clinical Microbiology Procedures Handbook, vol. 2. American Society for Microbiology, Washington, p. 8.26.1.
11. Kende M., Alving C.R., Rill W.L., Swartz G.M., Canonico P.G. Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob. Agents Chemother. 27:1985;903-907
12. Loftsson, T., 1995. Cyclodextrin Complexation. Cyclops h.f., Iceland, 31 pp. U.S. Pat. 5472954.
13. Nicolazzi C., Abdou S., Collomb J., Marsura A., Finance C. Effect of the complexation with cyclodextrins on the in vitro antiviral activity of ganciclovir against human cytomegalovirus. Bioorg. Med. Chem. 9:2001;275-282
14. Nicolazzi C., Venard V., Le Faou A., Finance C. In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains. Antiviral Res. 54:2002;121-127
15. Prokai L., Prokai-Tatrai K., Bodor N. Targeting drugs to the brain by redox chemical delivery systems. Med. Res. Rev. 20:2000;367-416
16. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., Robins R.K. Broad-spectrum antiviral activity of virazole: 1-β-D- ribofuranosyl-1, 2, 4-triazole-3-carboxamide. Science. 177:1972;705-706
17. Stogner S.W., King J.W., Black-Payne C., Bocchini J. Ribavirin and intravenous immune globulin therapy for measles pneumonia in HIV infection. South Med. J. 86:1993;1415-1418
18. Udata C., Patel J., Pal D., Hejchman E., Cushman M., Mitra A.K. Enhanced transport of a novel anti-HIV agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int. J. Pharm. 250:2003;157-168
19. Weiss R.C., Cox N.R., Martinez M.L. Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis. Res. Vet. Sci. 55:1993;162-172
20. WHO/UNICEF, 2001. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. Available: http:www.unicef.org/ pub_measles_statement_en.pdf (accessed September 3, 2003).